Kestra Advisory Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$811K Buy
1,496
+141
+10% +$72.9K ﹤0.01% 2109
2026
Q2
$734K Buy
1,355
+67
+5% +$37.7K ﹤0.01% 2037
2026
Q1
$764K Hold
1,288
– – ﹤0.01% 1918
2025
Q4
$628K Buy
1,288
+188
+17% +$87.6K ﹤0.01% 1980
2025
Q3
$461K Sell
1,100
-166
-13% -$55.8K ﹤0.01% 2121
2025
Q2
$364K Buy
1,266
+236
+23% +$70.5K ﹤0.01% 2212
2025
Q1
$318K Sell
1,030
-127
-11% -$43.5K ﹤0.01% 2137
2024
Q4
$408K Buy
1,157
+209
+22% +$76.8K ﹤0.01% 2016
2024
Q3
$340K Sell
948
-244
-20% -$82.4K ﹤0.01% 2018
2024
Q2
$380K Buy
1,192
+285
+31% +$75.4K ﹤0.01% 1968
2024
Q1
$208K Buy
+907
New +$205K ﹤0.01% 2247
2023
Q1
– Sell
-982
Closed -$273K – 2314
2022
Q4
$273K Buy
+982
New +$248K ﹤0.01% 1807
2022
Q3
– Sell
-1,052
Closed -$248K – 2243
2022
Q2
$248K Buy
+1,052
New +$214K ﹤0.01% 1756

Other funds holding UTHR

Kestra Advisory Services's UTHR Position: Q3 2026 in Review

Kestra Advisory Services increased its United Therapeutics (UTHR) stake by 10% in Q3 2026, buying an estimated $72.9K and bringing the position to 1,496 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Kestra Advisory Services first reported a position in UTHR in Q2 2022 and has held it in 13 quarters since. 276 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Kestra Advisory Services held 1,496 shares of United Therapeutics worth $811K as of Q3 2026.
  • Kestra Advisory Services bought 141 United Therapeutics shares in Q3 2026, an estimated $72.9K.
  • United Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2109 holding.
  • Kestra Advisory Services first reported a position in United Therapeutics in Q2 2022 and has held it in 13 quarters since.
  • 276 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.